H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 14.7% of adults in Milwaukee have diagnosed diabetes — 2.7 points above the U.S. 12% figure. Census population 577,222. Wisconsin Medicare wound biologics: National Government Services (NGS) (J6). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Milwaukee clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Milwaukee storefront.
Non-Surgical Regenerative Therapy Options in Milwaukee, WI for clinics & physicians. Give patients non-sur… Compliance support & pricing — contact Hawk Medical.
Two files matter before you open a box of non surgical regenerative therapy in Milwaukee: (1) CDC PLACES (2023, crude) estimates 14.7% of adults in Milwaukee have diagnosed diabetes — 2.7 points above the U.S. 12% figure. (2) Wisconsin Part B wound biologics are reviewed by National Government Services (NGS) under J6, shared with IL, MN. We help with the second file. We do not pretend to be a Milwaukee storefront.
National Non-Surgical Regenerative Therapy Options notes (how the product actually works)Wisconsin shares J6 with IL, MN. Florida is the only single-state MAC. CDC PLACES (2023, crude) estimates 14.7% of adults in Milwaukee have diagnosed diabetes — 2.7 points above the U.S. 12% figure. If you also operate in another contractor’s state, say so on the first call — we map both.
Named person, real rates, no fake address. Joe Bradley, founder, active practice owner. CDC PLACES (2023, crude) estimates 14.7% of adults in Milwaukee have diagnosed diabetes — 2.7 points above the U.S. 12% figure. Adult arthritis here is 23.8% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Schema on this site does not publish a fabricated star rating for Milwaukee.
CDC PLACES (2023, crude prevalence) estimates 14.7% of adults — 2.7 points above the U.S. 12% figure. Obesity is 41.8%; arthritis is 23.8%. That is place-level BRFSS modeling, not a clinic census and not a Milwaukee trial.
The allograft is used to perform the same basic function in the recipient as in the donor (FDA 361). Using umbilical or amniotic tissue as a marketed “stem cell cure” for unrelated conditions is outside that lane and is a Wisconsin compliance risk.
No. areaServed names the city we will ship to. It is not a claim that Hawk Medical is a Milwaukee medical practice or that we hold a local facility license.
Hawk Medical works with independent reps who already have physician call points. Territory conversations start at /become-a-rep — not by scraping this city URL.
Bring specialty, monthly joint / regenerative volume, and whether you bill J6 FFS, Advantage, workers’ comp, or cash-pay. We already have PLACES 14.7% diabetes and 23.8% arthritis for Milwaukee — tell us how that matches your panel. Book 15 minutes with Joe or use the contact form.
Contact us to learn how Hawk Medical supports practices in Milwaukee, WI.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Milwaukee is J6 geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Milwaukee — 2.7 points above the U.S. 12% figure. Planning input, not an outcomes claim.
Wisconsin Part B wound biologics follow this contractor (siblings: IL, MN). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Milwaukee. Useful for joint-program math; still needs a diagnosis and privileging.
No Milwaukee storefront. Joe Bradley is an active practice owner. non surgical regenerative therapy stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.